ANS-6637 (HLAB-002)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ANS-6637 (HLAB-002), covering 2022-03-10 to 2022-03-10. Get the full timeline:
Most recent: Clinical Trial Update: HLAB-002 of ANS-6637 for Alcohol Use Disorder [Phase 2]